Tin tức & Cập nhật

Chỉ hiển thị Multimedia
GLP-1 RAs reduce depression, substance use in young patients with obesity, MASLD

GLP-1 RAs reduce depression, substance use in young patients with obesity, MASLD

17 Jun 2025 bởiStephen Padilla

In paediatric patients with obesity and metabolic dysfunction-associated steatotic liver disease (MASLD), treatment with GLP-1 receptor agonists (RAs) results in a decrease in depression and substance use, as shown in a study presented at ESPGHAN 2025.

GLP-1 RAs reduce depression, substance use in young patients with obesity, MASLD

17 Jun 2025
DASH diet during pregnancy helps prevent LGA newborns

DASH diet during pregnancy helps prevent LGA newborns

11 Jun 2025
Fatigue prevalent in paediatric IBD patients

Fatigue prevalent in paediatric IBD patients

09 Jun 2025